99 related articles for article (PubMed ID: 12126158)
1. Myofiber expression of class I major histocompatibility complex accompanied by CD8+ T-cell-associated myofiber injury in a case of canine polymyositis.
Morita T; Shimada A; Yashiro S; Takeuchi T; Hikasa Y; Okamoto Y; Mabuchi Y
Vet Pathol; 2002 Jul; 39(4):512-5. PubMed ID: 12126158
[TBL] [Abstract][Full Text] [Related]
2. Evidence for MHC I-restricted CD8+ T-cell-mediated immunopathology in canine masticatory muscle myositis and polymyositis.
Neumann J; Bilzer T
Muscle Nerve; 2006 Feb; 33(2):215-24. PubMed ID: 16270307
[TBL] [Abstract][Full Text] [Related]
3. Polymyositis and polyarthritis associated with systemic lupus erythematosus in a dog.
Krum SH; Cardinet GH; Anderson BC; Holliday TA
J Am Vet Med Assoc; 1977 Jan; 170(1):61-4. PubMed ID: 830633
[TBL] [Abstract][Full Text] [Related]
4. [The immunoreactivity studies of the idiopathic inflammatory myopathy over the past three years in our laboratory].
Hiruma S; Ohtsuka K; Satou T; Furuta T; Kimura M; Hashimoto S
Rinsho Byori; 1998 Feb; 46(2):168-75. PubMed ID: 9528342
[TBL] [Abstract][Full Text] [Related]
5. Evidence for MHC-1-restricted CD8+ T-cell-mediated immunopathology in canine masticatory muscle myositis and polymyositis.
Shelton GD; Paciello O
Muscle Nerve; 2006 Jul; 34(1):122; author reply 122-3. PubMed ID: 16583372
[No Abstract] [Full Text] [Related]
6. Temporal alterations of immunohistochemical findings in polymyositis.
Tajima Y; Moriwaka F; Tashiro K
Intern Med; 1994 May; 33(5):263-70. PubMed ID: 7949628
[TBL] [Abstract][Full Text] [Related]
7. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity.
Schmidt J; Rakocevic G; Raju R; Dalakas MC
Brain; 2004 May; 127(Pt 5):1182-90. PubMed ID: 15047591
[TBL] [Abstract][Full Text] [Related]
8. The diagnosis and classification of polymyositis.
Milisenda JC; Selva-O'Callaghan A; Grau JM
J Autoimmun; 2014; 48-49():118-21. PubMed ID: 24461380
[TBL] [Abstract][Full Text] [Related]
9. Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis.
Dorph C; Englund P; Nennesmo I; Lundberg IE
Ann Rheum Dis; 2006 Dec; 65(12):1565-71. PubMed ID: 16831829
[TBL] [Abstract][Full Text] [Related]
10. Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies.
Englund P; Lindroos E; Nennesmo I; Klareskog L; Lundberg IE
Am J Pathol; 2001 Oct; 159(4):1263-73. PubMed ID: 11583954
[TBL] [Abstract][Full Text] [Related]
11. Expression of CCR7 and its ligands CCL19/CCL21 in muscles of polymyositis.
Tateyama M; Fujihara K; Misu T; Feng J; Onodera Y; Itoyama Y
J Neurol Sci; 2006 Nov; 249(2):158-65. PubMed ID: 16887149
[TBL] [Abstract][Full Text] [Related]
12. Major histocompatibility complex and inflammatory cell subtype expression in inflammatory myopathies and muscular dystrophies.
Nagappa M; Nalini A; Narayanappa G
Neurol India; 2013; 61(6):614-21. PubMed ID: 24441329
[TBL] [Abstract][Full Text] [Related]
13. Polymyositis mediated by T lymphocytes that express the gamma/delta receptor.
Hohlfeld R; Engel AG; Ii K; Harper MC
N Engl J Med; 1991 Mar; 324(13):877-81. PubMed ID: 1705662
[TBL] [Abstract][Full Text] [Related]
14. A new murine model to define the critical pathologic and therapeutic mediators of polymyositis.
Sugihara T; Sekine C; Nakae T; Kohyama K; Harigai M; Iwakura Y; Matsumoto Y; Miyasaka N; Kohsaka H
Arthritis Rheum; 2007 Apr; 56(4):1304-14. PubMed ID: 17394136
[TBL] [Abstract][Full Text] [Related]
15. Masticatory and skeletal muscle myositis in canine leishmaniasis (Leishmania infantum).
Vamvakidis CD; Koutinas AF; Kanakoudis G; Georgiadis G; Saridomichelakis M
Vet Rec; 2000 Jun; 146(24):698-703. PubMed ID: 10887983
[TBL] [Abstract][Full Text] [Related]
16. [MHC class I antigens, CD4 and CD8 expressions in polymyositis and dermatomyositis].
Graça CR; Kouyoumdjian JA
Rev Bras Reumatol; 2015; 55(3):203-8. PubMed ID: 25600456
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics and muscle histopathology in polymyositis positive anti-hepatitis with C virus antibody].
Ayabe M; Kawamoto M; Ijima H; Hino H; Shoji H
Rinsho Shinkeigaku; 1997 Mar; 37(3):208-11. PubMed ID: 9217418
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of lysis by activated cytotoxic cells expressing perforin and granzyme-B genes and the protein TIA-1 in muscle biopsies of myositis.
Cherin P; Herson S; Crevon MC; Hauw JJ; Cervera P; Galanaud P; Emilie D
J Rheumatol; 1996 Jul; 23(7):1135-42. PubMed ID: 8823683
[TBL] [Abstract][Full Text] [Related]
19. Expression of Major Histocompatibility Complex class I and II in a case of Neospora caninum myositis in a dog.
Paciello O; D'Orazi A; Borzacchiello G; Martano M; Restucci B; Maiolino P; Papparella S
Acta Myol; 2004 Dec; 23(3):151-3. PubMed ID: 15938572
[TBL] [Abstract][Full Text] [Related]
20. Pathogenic aspects of dermatomyositis, polymyositis and overlap myositis.
Gherardi RK
Presse Med; 2011 Apr; 40(4 Pt 2):e209-18. PubMed ID: 21376512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
